Posted by: Indonesian Children | January 14, 2009

FREE DOWNLOAD ARTICLES : INTERNET RESOURCES HIV AIDS IN CHILDREN

BIBLIOGRAPHY AND INTERNET RESOURCES OF HIV AIDS IN
 CHILDREN
.

BIBLIOGRAPHY

  1. Mann, J., D. Tarantola, and T. Netter. 1992. AIDS in the World. Cambridge, MA: Harvard University Press.
  2. Schenker, Inon. 2001. “New Challenges for School AIDS Education within an Evolving HIV Pandemic.” Prospects 31, no 3: 415-434.
  3. Schenker, Inon, G. Sabar-Friedman, and S. S. Sy. 1996. AIDS Education–Interventions in Multi-Cultural Societies. New York: Plenum Press.
  4. World Bank. 2002. Education and HIV/AIDS: A Window of Hope. Washington, DC: World Bank.
  5. AAP: Perinatal human immunodeficiency virus testing. Provisional Committee on Pediatric
  6. AIDS, American Academy of Pediatrics. Pediatrics 1995 Feb; 95(2): 303-7[Medline].
    Branson BM: Rapid tests for HIV antibody [serial online]. 2000; Available at: http://www.aidsreviews.com%5BFull Text].
  7. CDC: Public Health Service Task Force recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR Recomm Rep 1998 Jan 30; 47(RR-2): 1-30
  8. de Martino M, Tovo PA, Balducci M, et al: Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection: Italian Register for HIV Infection in Children and the Italian National AIDS Registry. JAMA 2000 Jul 12; 284(2): 190-7[Medline].
  9. International Perinatal HIV Group: The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1–a meta-analysis of 15 prospective cohort studies: the International Perinatal HIV Group. N Engl J Med 1999 Apr 1; 340(13): 977-87[Medline].
  10. John Hopkins AIDS Service: Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Available at: http://hopkins-aids.edu/. 2000.[Full Text].
  11. Kovacs JA, Masur H: Prophylaxis against opportunistic infections in patients with human immunodeficiency virus infection. N Engl J Med 2000 May 11; 342(19): 1416-29[Medline].
  12. Lindegren ML, Steinberg S, Byers RH Jr: Epidemiology of HIV/AIDS in children. Pediatr Clin North Am 2000 Feb; 47(1): 1-20, v[Medline].
  13. Mofenson LM, Lambert JS, Stiehm ER, et al: Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine: Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med 1999 Aug 5; 341(6): 385-93[Medline].
  14. Nielsen K: Pediatric HIV infection. HIV Clinical Management. 1999; Available at: http://www.medscape.com/hiv-aidshome%5BFull Text].
  15. Pizzo PA, Wilfert CM, eds.: Pediatric AIDS: The challenge of HIV infection in infants, children and adolescents. 3rd ed. Baltimore, Md: Lippincott, Williams & Wilkins; 1998.
  16. Ray PE, Rakusan T, Loechelt BJ, et al: Human immunodeficiency virus (HIV)-associated nephropathy in children from the Washington, D.C. area: 12 years’ experience. Semin Nephrol 1998 Jul; 18(4): 396-405[Medline].
  17. Rouet F, Sakarovitch C, Msellati P, et al: Pediatric viral human immunodeficiency virus type 1 RNA levels, timing of infection, and disease progression in African HIV-1-infected children. Pediatrics 2003 Oct; 112(4): e289[Medline].
  18. World Health Organization. Paediatric HIV and treatment of children living with HIV. Available at http://www.who.int/hiv/paediatric/en/index.html. Accessed 2006.
  19. Garrib A, Jaffar S, Knight S, Bradshaw D, Bennish ML. Rates and causes of child mortality in an area of high HIV prevalence in rural South Africa. Tropical Medicine and International Health. Dec 2006;11 (12):1841-1848. [Medline].
  20. Chiou CC, Groll AH, Gonzalez CE, Callender D, Venzon D, Pizzo PA, et al. Esophageal candidiasis in pediatric acquired immunodeficiency syndrome: clinical manifestations and risk factors. Pediatr Infect Dis J. Aug 2000;19(8):729-34. [Medline].
  21. Brown DM, Jabra-Rizk MA, Falkler WA, Baqui AA, Meiller TF. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients. Pediatr Dent. May-Jun 2000;22(3):234-8. [Medline].
  22. Pongsiriwet S, Iamaroon A, Kanjanavanit S, Pattanaporn K, Krisanaprakornkit S. Oral lesions and dental caries status in perinatally HIV-infected children in Northern Thailand. Int J Paediatr Dent. May 2003;13(3):180-5. [Medline].
  23. Tofsky N, Nelson EM, Lopez RN, Catalanotto FA, Fine DH, Katz RV. Dental caries in HIV-infected children versus household peers: two-year findings. Pediatr Dent. May-Jun 2000;22(3):207-14. [Medline].
  24. Dias EP, Israel MS, Silva Junior A, Maciel VA, Gagliardi JP, Oliveira RH. Prevalence of oral hairy leukoplakia in 120 pediatric patients infected with HIV-1. Braz Oral Res. Apr-Jun 2006;20(2):103-7. [Medline].
  25. Mohle-Boetani JC, Koehler JE, Berger TG, LeBoit PE, Kemper CA, Reingold AL, et al. Bacillary angiomatosis and bacillary peliosis in patients infected with human immunodeficiency virus: clinical characteristics in a case-control study. Clin Infect Dis. May 1996;22(5):794-800. [Medline].
  26. Perry RT, Mmiro F, Ndugwa C, Semba RD. Measles infection in HIV-infected African infants. Ann N Y Acad Sci. Nov 2000;918:377-80. [Medline].
  27. Enwonwu CO, Falkler WA Jr, Idigbe EO, Savage KO. Noma (cancrum oris): questions and answers. Oral Dis. Apr 1999;5(2):144-9. [Medline].
  28. Jaquet D, Levine M, Ortega-Rodriguez E, Faye A, Polak M, Vilmer E, et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS. Sep 2000;14(14):2123-8. [Medline].
  29. Chiarelli F, Galli L, Verrotti A, di Ricco L, Vierucci A, de Martino M. Thyroid function in children with perinatal human immunodeficiency virus type 1 infection. Thyroid. Jun 2000;10(6):499-505. [Medline].
  30. Smith KJ, Skelton HG 3rd, Vogel P, Yeager J, Baxter D, Wagner KF. Exaggerated insect bite reactions in patients positive for HIV. Military Medical Consortium for the Advancement of Retroviral Research. J Am Acad Dermatol. Aug 1993;29(2 Pt 1):269-72. [Medline].
  31. Kest H, Brogly S, McSherry G, Dashefsky B, Oleske J, Seage GR. Malignancy in perinatally human immunodeficiency virus-infected children in the United States. Pediatr Infect Dis J. Mar 2005;24(3):237-42. [Medline].
  32. Ziegler JL, Katongole-Mbidde E. Kaposi’s sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer. Jan 17 1996;65(2):200-3. [Medline].
  33. Working Group on Antiretroviral Therapy and Medical Management of HIV infected C, Health Resources and Services Administration. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. National Institutes of Health. Available at http://aidsinfo.nih.gov/ContentFiles/PediatricGuidelines.pdf. Accessed 2006.
  34. Center for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR Recomm Rep. Apr 17 1998;47(RR-4):1-43. [Medline].
  35. Benjamin DK Jr, Miller WC, Benjamin DK, Ryder RW, Weber DJ, Walter E, et al. A comparison of height and weight velocity as a part of the composite endpoint in pediatric HIV. AIDS. Nov 7 2003;17(16):2331-6. [Medline].
  36. Benakappa A, Benakappa N, Benakappa DG. Management of tuberculosis. Indian J Pediatr. Sep-Oct 1995;62(5):557-63. [Medline].
  37. Blanche S, Tovo PA. European epidemiology. In: Pizzo PA, Wilfert CM. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998:13-22.
  38. Bohler T, Wintergerst U, Linde R, Belohradsky BH, Debatin KM. CD95 (APO-1/Fas) expression on naive CD4(+) T cells increases with disease progression in HIV-infected children and adolescents: effect of highly active antiretroviral therapy (HAART). Pediatr Res. Jan 2001;49(1):101-10. [Medline].
  39. Capaldini L. Psychosocial issues and psychiatric complications of HIV disease. In: Sande MA, Volberding PA. The Medical Management of AIDS. 6th ed. Philadelphia, Pa: WB Saunders; 1999:241-63.
  40. Caselli D, Klersy C, de Martino M, Gabiano C, Galli L, Tovo PA, et al. Human immunodeficiency virus-related cancer in children: incidence and treatment outcome–report of the Italian Register. J Clin Oncol. Nov 15 2000;18(22):3854-61. [Medline].
  41. Centers for Disease Control and Prevention. 1994 Revised classification system for human immunodeficiency virusinfection in children less than 13 years of age. MMWR. 1994;43 (No. RR-12):1-10.
  42. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report: HIV Infection and AIDS in the United States and Dependent Areas. Department of Health and Human Services. Available at http://www.cdc.gov/hiv/topics/surveillance/basic.htm.
  43. Centers for Disease Control and Prevention. National Center for HIV, STD and TB prevention: Division of HIV/AIDS Prevention. Department of Health and Human Services. Available at http://www.cdc.gov/hiv/dhap.htm. Accessed 2005.
  44. Centers for Disease Control and Prevention. 1994 revised guidelines for the performance of CD4+ T-cell determinations in persons with human immunodeficiency virus (HIV) infections. MMWR Recomm Rep. Mar 4 1994;43(RR-3):1-21. [Medline].
  45. Chang MW, Orlow SJ. Molluscum contagiosum in children: When and how to treat. Consultant. 1998;1593-1599.
  46. Clerici M, Saresella M, Colombo F, Fossati S, Sala N, Bricalli D, et al. T-lymphocyte maturation abnormalities in uninfected newborns and children with vertical exposure to HIV. Blood. Dec 1 2000;96(12):3866-71. [Medline].
  47. Cohen H, Chen XC, Sunkle S, Davis L, Geromanos K, Xanthos G, et al. Ability of caregivers to read delayed hypersensitivity skin tests in children exposed to and infected by HIV. The Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Study Group. J Pediatr Health Care. Mar-Apr 2000;14(2):50-5. [Medline].
  48. D’Angelo LJ. Sexually transmitted diseases in children and adolescents with HIV infection. In: Pizzo PA, Wilfert CM. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998:169-182.
  49. Epocrates. Drug Information. Epocrates Online. Available at http://www.epocrates.com/. Accessed 2007.
  50. Gondim LA, Zonta RF, Fortkamp E, Schmeling RO. Otorhinolaryngological manifestations in children with human immunodeficiency virus infection. Int J Pediatr Otorhinolaryngol. Aug 31 2000;54(2-3):97-102. [Medline].
  51. Greenberg AE, Dabis F, Marum LH. HIV infection in Africa. In: Pizzo PA, Wilfert CM. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Lippincott Williams & Wilkins; 1998::23-46.
  52. Hansen RD, Raja C, Allen BJ. Total body protein in chronic diseases and in aging. Ann N Y Acad Sci. May 2000;904:345-52. [Medline].
  53. Hines SE. Primary care for HIV-exposed and infected children: translating progress into practice. Lippincotts Prim Care Pract. Jan-Feb 2000;4(1):43-65. [Medline].
  54. Howland LC, Gortmaker SL, Mofenson LM, Spino C, Gardner JD, Gorski H, et al. Effects of negative life events on immune suppression in children and youth infected with human immunodeficiency virus type 1. Pediatrics. Sep 2000;106(3):540-6. [Medline].
  55. Joint United Nations Programme on HIV/AIDS. UNAIDS/WHO AIDS Update. Available at www.unaids.org/wad2004/report.html. Accessed 2004.
  56. Joint United Nations Programme on HIV/AIDS. UNAIDS/WHO epidemiological fact sheets on HIV/AIDS and Sexually Transmitted Infections, Update, India. Available at www.unaids.org/wad2004/factsheets.html. Accessed 2004.
  57. Kline MW. Pediatric HIV Infection. Baylor International Pediatric AIDS Initiative–Educational Resources. 2005.
  58. Kovacs A, Scott GB. Advances in the management and care of HIV-positive newborns and infants. In: Pizzo PA, Wilfert CM. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998:567-92.
  59. Laude TA. Manifestations of HIV disease in children. Clin Dermatol. Jul-Aug 2000;18(4):457-67. [Medline].
  60. Layton TL, Davis-McFarland E. Pediatric human immunodeficiency virus and acquired immunodeficiency syndrome: an overview. Semin Speech Lang. 2000;21(1):7-17. [Medline].
  61. Leandro-Merhi VA, Vilela MM, Silva MN, Lopez FA, Barros Filho A. Evolution of nutritional status of infants infected with the human immunodeficiency virus. Sao Paulo Med J. Sep 7 2000;118(5):148-53. [Medline].
  62. Mastro TD, Zhang KL, Panda S. HIV infection and AIDS in Asia. In: Pizzo PA, Wilfert CM, eds. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998:47-63.
    64. McIntosh K. Human immunodeficiency virus: the virus and its pathogenicity. In: Yogev R, Connor E. Management of HIV Infection in Infants and Children. Mosby-Year Book; 1992::35-51.
  63. Medical Economics Staff. Physician’s Desk Reference. 55th ed. Montvale, NJ: Medical Economics Company; 2001:472-8, 499-503, 1374-7, 1456-60, 2838-42, 3482-7.
  64. Mueller BU. HIV-associated malignancies in children. AIDS Patient Care STDS. Sep 1999;13(9):527-33. [Medline].
  65. Naidoo S, Chikte U. Oro-facial manifestations in paediatric HIV: a comparative study of institutionalized and hospital outpatients. Oral Dis. Jan 2004;10(1):13-8. [Medline].
  66. National Institutes of Health, National Institue of Allergy and Infectious Disease, US Dept of Health and Human Services. HIV Infection in Minority Populations. 2005;[Full Text].
  67. Ndour M, Sow PS, Coll-Seck AM, Badiane S, Ndour CT, Diakhate N, et al. AIDS caused by HIV1 and HIV2 infection: are there clinical differences? Results of AIDS surveillance 1986-97 at Fann Hospital in Dakar, Senegal. Trop Med Int Health. Oct; 2000;5(10):687-91. [Medline].
  68. Padhani DH, Manji KP, Mtanda AT. Ocular manifestations in children with HIV infection in Dar es Salaam, Tanzania. J Trop Pediatr. Jun 2000;46(3):145-8. [Medline].
  69. Penneys NS, ed. Bacterial and complex infections. In: Skin Manifestations of AIDS. 2nd ed. St Louis, Mo: Mosby-Year Book; 1995:50-74.
  70. Portela MB, Souza IP, Costa EM, Hagler AN, Soares RM, Santos AL. Differential recovery of Candida species from subgingival sites in human immunodeficiency virus-positive and healthy children from Rio de Janeiro, Brazil. J Clin Microbiol. Dec 2004;42(12):5925-7. [Medline].
  71. Raju PV, Rao GR, Ramani TV, Vandana S. Skin disease: clinical indicator of immune status in human immunodeficiency virus (HIV) infection. Int J Dermatol. Aug; 2005;44(8):646-9. [Medline].
  72. Ramos-Gomez F. Dental considerations for the paediatric AIDS/HIV patient. Oral Dis. 2002;8 Suppl 2:49-54. [Medline].
  73. Rogers MF, Lindegren ML, Simonds RJ. Pediatric HIV infection in the United States. In: Pizzo PA, Wilfert CM,. Pediatric AIDS: The Challenge of HIV Infection in Infants, Children, and Adolescents. 3rd ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 1998:3-11.
  74. Rongkavilit C, Mitchell CD, Nachman S. Varicella zoster infection in HIV-infected children. Paediatr Drugs. Jul-Aug 2000;2(4):291-7. [Medline].
  75. Shearer WT, Easley KA, Goldfarb J, Jenson HB, Rosenblatt HM, Kovacs A, et al. Evaluation of immune survival factors in pediatric HIV-1 infection. Ann N Y Acad Sci. Nov 2000;918:298-312. [Medline].
  76. Smith R, Malee K, Charurat M, Magder L, Mellins C, Macmillan C, et al. Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. The Women and Infant Transmission Study Group. Pediatr Infect Dis J. Sep 2000;19(9):862-71. [Medline].
  77. Solomon BA, Laude TA. A peculiar annular eruption in a child with AIDS. J Am Acad Dermatol. Sep 1995;33(3):513-4. [Medline].
  78. Stefanaki C, Stratigos AJ, Stratigos JD. Skin manifestations of HIV-1 infection in children. Clin Dermatol. Jan-Feb 2002;20(1):74-86. [Medline].
  79. Straka BF, Whitaker DL, Morrison SH, Oleske JM, Grant-Kels JM. Cutaneous manifestations of the acquired immunodeficiency syndrome in children. J Am Acad Dermatol. May 1988;18(5 Pt 1):1089-102. [Medline].
  80. Taha TE, Nour S, Kumwenda NI, Broadhead RL, Fiscus SA, Kafulafula G, et al. Gender differences in perinatal HIV acquisition among African infants. Pediatrics. Feb 2005;115(2):e167-72. [Medline].
  81. Thomas P, Bornschlegel K, Singh TP, Abrams EJ, Cervia J, Fikrig S, et al. Tuberculosis in human immunodeficiency virus-infected and human immunodeficiency virus-exposed children in New York City. The New York City Pediatric Spectrum of HIV Disease Consortium. Pediatr Infect Dis J. Aug 2000;19(8):700-6. [Medline].
  82. UNAIDS, UNICEF, USAID. Children on the Brink 2004: A joint report of new orphan estimates and a framework for action. UNICEF. Available at http://www.unicef.org/publications/index_22212.html. Accessed 2004.
  83. UNAIDS, WHO. UNAIDS/WHO AIDS Epidemic Update:. UNAIDS. Available at http://www.unaids.org/en/HIV_data/epi2006/default.asp. Accessed 2006.
  84. von Seidlein L, Gillette SG, Bryson Y, Frederick T, Mascola L, Church J, et al. Frequent recurrence and persistence of varicella-zoster virus infections in children infected with human immunodeficiency virus type 1. J Pediatr. Jan 1996;128(1):52-7. [Medline].
  85. Weedon D, ed. The spongiotic reaction pattern. In: Skin Pathology. New York, NY: Churchill Livingstone; 1997:83-107.
  86. Weedon D, ed. Mycoses and algal infections. In: Skin Pathology. New York, NY: Churchill Livingstone; 1997:555-582.
  87. Weedon D, ed. Vascular tumors. In: Skin Pathology. New York, NY: Churchill Livingstone; 1997:821-854.
  88. Whitworth JM, Janniger CK, Oleske JM, Schwartz RA. Cutaneous manifestations of childhood acquired immunodeficiency syndrome and human immunodeficiency virus infection. Cutis. Feb 1995;55(2):62-6, 70-2. [Medline].
  89. Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infectioin. Developed by Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children. National Institutes of Health. Available at http://aidsinfo.nih.gov/. Accessed 2005.
  90. World Health Organization. The World Health Report: Global Health–today’s challenges. Available at http://www.who.int/whr/2003/en/Chapter1.pdf. Accessed 2005.

INTERNET RESOURCES

 

Supported  by
FIGHT AGAINTS AIDS, SAVE INDONESIAN CHILDRENS

Yudhasmara Foundation

Working together against HIV and Aids in Indonesia, Save our Children From HIV-AIDS

 

Office ; JL Taman Bendungan Asahan 5 Jakarta Indonesia 10210

phone : 62(021) 70081995 – 5703646

email : judarwanto@gmail.com,

https://childrenhivaids.wordpress.com/

 

 

 

Editor in Chief :

Dr WIDODO JUDARWANTO

phone : 62(021) 70081995 – 62(021) 5703646, mobile : 0817171764

email : judarwanto@gmail.com

 

 

Copyright © 2009, Fight Against Aids, Save Indonesian Childrens Information Education Network. All rights reserved.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

Categories

%d bloggers like this: